epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Adstiladrin (nadofaragene firadenovec-vncg)

nadofaragene firadenovec intravesical

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  SUSPENSION

Special Note

[drug name clarification]
Info: nonproprietary name = nadofaragene firadenovec-vncg
[uses, dosing may vary]
Info: refer to institution protocols and pkg insert prior to prescribing for uses, premeds, and dosing including toxicity-related dose adjustments

non-muscle invasive bladder CA in situ, BCG-refractory

[75 mL intravesically q3mo]
Info: for high-risk patients with or without papillary tumors; consider cystectomy if complete response not achieved after 3mo or disease recurs

renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@769a4cf6
  • hypersensitivity to drug or ingredient
  • hypersensitivity to interferon alfa
  • avoid: handling drug (immunocompromised individuals)
  • caution: immunocompromised patients
  • caution: patients of childbearing potential
  • caution: male patients of reproductive potential

Drug Interactions .

Overview

nadofaragene firadenovec intravesical

gene therapy

Interaction Characteristics:
  • immunomodulatory infective agent

Avoid/Use Alternative

  • infliximab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    infliximab
    1 interaction

    Avoid/Use Alternative

    nadofaragene firadenovec intravesical + infliximab

    avoid combo: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

Monitor/Modify Tx

  • mitomycin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    nadofaragene firadenovec intravesical + mitomycin

    caution advised; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

Caution Advised

  • abatacept
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    abatacept
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + abatacept

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • abrocitinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    abrocitinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + abrocitinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • acalabrutinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    acalabrutinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + acalabrutinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • adalimumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    adalimumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + adalimumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • afamitresgene autoleucel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    afamitresgene autoleucel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + afamitresgene autoleucel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • aldesleukin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    aldesleukin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + aldesleukin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • alemtuzumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    alemtuzumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + alemtuzumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • anakinra
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    anakinra
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + anakinra

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • anifrolumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    anifrolumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + anifrolumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • anti-thymocyte globulin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    anti-thymocyte globulin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + anti-thymocyte globulin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • atidarsagene autotemcel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    atidarsagene autotemcel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + atidarsagene autotemcel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • avacopan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    avacopan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + avacopan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • axicabtagene ciloleucel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    axicabtagene ciloleucel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + axicabtagene ciloleucel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • azacitidine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    azacitidine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + azacitidine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • azathioprine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    azathioprine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + azathioprine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • baricitinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    baricitinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + baricitinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • basiliximab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    basiliximab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + basiliximab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • belatacept
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    belatacept
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + belatacept

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • belimumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    belimumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + belimumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • belinostat
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    belinostat
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + belinostat

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • bendamustine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    bendamustine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + bendamustine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • betamethasone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    betamethasone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + betamethasone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • bimekizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    bimekizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + bimekizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • blinatumomab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    blinatumomab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + blinatumomab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • bortezomib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    bortezomib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + bortezomib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • brentuximab vedotin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    brentuximab vedotin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + brentuximab vedotin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • brexucabtagene autoleucel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    brexucabtagene autoleucel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + brexucabtagene autoleucel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • brodalumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    brodalumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + brodalumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • budesonide
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    budesonide
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + budesonide

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • budesonide rectal
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    budesonide rectal
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + budesonide rectal

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • busulfan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    busulfan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + busulfan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • cabazitaxel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    cabazitaxel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + cabazitaxel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • canakinumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    canakinumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + canakinumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • carboplatin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    carboplatin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + carboplatin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • carfilzomib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    carfilzomib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + carfilzomib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • carmustine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    carmustine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + carmustine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • certolizumab pegol
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    certolizumab pegol
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + certolizumab pegol

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • chlorambucil
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    chlorambucil
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + chlorambucil

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ciltacabtagene autoleucel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ciltacabtagene autoleucel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ciltacabtagene autoleucel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • cisplatin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    cisplatin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + cisplatin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • cladribine injection
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    cladribine injection
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + cladribine injection

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • cladribine oral
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    cladribine oral
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + cladribine oral

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • clofarabine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    clofarabine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + clofarabine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • copanlisib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    copanlisib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + copanlisib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • corticotropin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    corticotropin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + corticotropin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • cortisone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    cortisone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + cortisone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • crovalimab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    crovalimab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + crovalimab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • cyclophosphamide
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    cyclophosphamide
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + cyclophosphamide

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • cyclosporine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    cyclosporine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + cyclosporine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • cytarabine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    cytarabine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + cytarabine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • dacarbazine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    dacarbazine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + dacarbazine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • dactinomycin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    dactinomycin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + dactinomycin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • danicopan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    danicopan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + danicopan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • daratumumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    daratumumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + daratumumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • daunorubicin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    daunorubicin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + daunorubicin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • deflazacort
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    deflazacort
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + deflazacort

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • delgocitinib topical
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    delgocitinib topical
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + delgocitinib topical

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • deucravacitinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    deucravacitinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + deucravacitinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • deuruxolitinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    deuruxolitinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + deuruxolitinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (additive effects)

  • dexamethasone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    dexamethasone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + dexamethasone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • dimethyl fumarate
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    dimethyl fumarate
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + dimethyl fumarate

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • dinutuximab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    dinutuximab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + dinutuximab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • diroximel fumarate
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    diroximel fumarate
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + diroximel fumarate

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • docetaxel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    docetaxel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + docetaxel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • doxorubicin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    doxorubicin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + doxorubicin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • dupilumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    dupilumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + dupilumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • duvelisib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    duvelisib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + duvelisib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • eculizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    eculizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + eculizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • efgartigimod alfa
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    efgartigimod alfa
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + efgartigimod alfa

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • elivaldogene autotemcel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    elivaldogene autotemcel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + elivaldogene autotemcel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • elotuzumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    elotuzumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + elotuzumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • elranatamab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    elranatamab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + elranatamab

    caution advised: combo may incr. risk of disseminated adenovirus infection (additive effects)

  • emapalumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    emapalumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + emapalumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • epcoritamab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    epcoritamab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + epcoritamab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • epirubicin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    epirubicin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + epirubicin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • eribulin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    eribulin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + eribulin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • etanercept
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    etanercept
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + etanercept

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • etoposide
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    etoposide
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + etoposide

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • etrasimod
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    etrasimod
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + etrasimod

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • etuvetidigene autotemcel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    etuvetidigene autotemcel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + etuvetidigene autotemcel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • everolimus
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    everolimus
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + everolimus

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • fingolimod
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    fingolimod
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + fingolimod

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • floxuridine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    floxuridine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + floxuridine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • fludarabine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    fludarabine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + fludarabine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • fludrocortisone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    fludrocortisone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + fludrocortisone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • fruquintinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    fruquintinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + fruquintinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • gemtuzumab ozogamicin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    gemtuzumab ozogamicin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + gemtuzumab ozogamicin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • glofitamab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    glofitamab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + glofitamab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • golimumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    golimumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + golimumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • guselkumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    guselkumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + guselkumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • hydrocortisone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    hydrocortisone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + hydrocortisone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • hydroxyurea
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    hydroxyurea
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + hydroxyurea

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ibritumomab tiuxetan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ibritumomab tiuxetan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ibritumomab tiuxetan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ibrutinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ibrutinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ibrutinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • icotrokinra
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    icotrokinra
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + icotrokinra

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • idarubicin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    idarubicin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + idarubicin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • idecabtagene vicleucel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    idecabtagene vicleucel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + idecabtagene vicleucel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • idelalisib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    idelalisib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + idelalisib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ifosfamide
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ifosfamide
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ifosfamide

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • inebilizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    inebilizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + inebilizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • inotuzumab ozogamicin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    inotuzumab ozogamicin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + inotuzumab ozogamicin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • iptacopan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    iptacopan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + iptacopan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • irinotecan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    irinotecan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + irinotecan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • isatuximab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    isatuximab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + isatuximab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ixabepilone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ixabepilone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ixabepilone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ixekizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ixekizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ixekizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • lebrikizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    lebrikizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + lebrikizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • leflunomide
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    leflunomide
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + leflunomide

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • lenalidomide
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    lenalidomide
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + lenalidomide

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • lifileucel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    lifileucel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + lifileucel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • linvoseltamab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + linvoseltamab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • lisocabtagene maraleucel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    lisocabtagene maraleucel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + lisocabtagene maraleucel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • lomustine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    lomustine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + lomustine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • loncastuximab tesirine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    loncastuximab tesirine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + loncastuximab tesirine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • lymphocyte immune globulin, anti-thymocyte globulin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    lymphocyte immune globulin, anti-thymocyte globulin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + lymphocyte immune globulin, anti-thymocyte globulin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • melphalan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    melphalan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + melphalan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • mercaptopurine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    mercaptopurine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + mercaptopurine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • methotrexate
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    methotrexate
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + methotrexate

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • methylprednisolone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    methylprednisolone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + methylprednisolone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • mirikizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    mirikizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + mirikizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • mitoxantrone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    mitoxantrone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + mitoxantrone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • mogamulizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    mogamulizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + mogamulizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • momelotinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    momelotinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + momelotinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • monomethyl fumarate
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    monomethyl fumarate
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + monomethyl fumarate

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • mosunetuzumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + mosunetuzumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • mycophenolate mofetil
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + mycophenolate mofetil

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • mycophenolic acid
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    mycophenolic acid
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + mycophenolic acid

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • narsoplimab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    narsoplimab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + narsoplimab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • natalizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    natalizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + natalizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • nelarabine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    nelarabine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + nelarabine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • nipocalimab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    nipocalimab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + nipocalimab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • obecabtagene autoleucel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    obecabtagene autoleucel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + obecabtagene autoleucel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • obinutuzumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    obinutuzumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + obinutuzumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ocrelizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ocrelizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ocrelizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ofatumumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ofatumumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ofatumumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • oxaliplatin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    oxaliplatin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + oxaliplatin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ozanimod
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ozanimod
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ozanimod

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • paclitaxel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    paclitaxel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + paclitaxel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • pacritinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    pacritinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + pacritinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • pegcetacoplan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    pegcetacoplan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + pegcetacoplan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • peginterferon alfa 2a
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    peginterferon alfa 2a
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + peginterferon alfa 2a

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • pentostatin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    pentostatin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + pentostatin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • pimecrolimus topical
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    pimecrolimus topical
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + pimecrolimus topical

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • pirtobrutinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    pirtobrutinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + pirtobrutinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • polatuzumab vedotin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    polatuzumab vedotin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + polatuzumab vedotin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ponesimod
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ponesimod
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ponesimod

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • pozelimab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    pozelimab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + pozelimab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • prednisolone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    prednisolone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + prednisolone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • prednisone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    prednisone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + prednisone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • procarbazine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    procarbazine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + procarbazine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ravulizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ravulizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ravulizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • regorafenib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    regorafenib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + regorafenib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • rilonacept
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    rilonacept
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + rilonacept

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • rilzabrutinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    rilzabrutinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + rilzabrutinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • risankizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    risankizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + risankizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ritlecitinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ritlecitinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ritlecitinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • rituximab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    rituximab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + rituximab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • romidepsin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    romidepsin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + romidepsin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ropeginterferon alfa-2b
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ropeginterferon alfa-2b
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ropeginterferon alfa-2b

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • rozanolixizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    rozanolixizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + rozanolixizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ruxolitinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ruxolitinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ruxolitinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ruxolitinib topical
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ruxolitinib topical
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ruxolitinib topical

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • sarilumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    sarilumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + sarilumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • satralizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    satralizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + satralizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • secukinumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    secukinumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + secukinumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • selinexor
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    selinexor
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + selinexor

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • sibeprenlimab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    sibeprenlimab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + sibeprenlimab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • siltuximab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    siltuximab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + siltuximab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • siponimod
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    siponimod
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + siponimod

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • sirolimus
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    sirolimus
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + sirolimus

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • sirolimus albumin-bound
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    sirolimus albumin-bound
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + sirolimus albumin-bound

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • spesolimab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    spesolimab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + spesolimab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • sulfasalazine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    sulfasalazine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + sulfasalazine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • sutimlimab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    sutimlimab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + sutimlimab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • tacrolimus
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    tacrolimus
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + tacrolimus

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • tafasitamab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    tafasitamab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + tafasitamab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • talquetamab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    talquetamab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + talquetamab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • tarlatamab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    tarlatamab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + tarlatamab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • teclistamab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    teclistamab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + teclistamab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • temozolomide
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    temozolomide
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + temozolomide

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • temsirolimus
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    temsirolimus
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + temsirolimus

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • teplizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    teplizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + teplizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • teriflunomide
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    teriflunomide
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + teriflunomide

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • thioguanine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    thioguanine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + thioguanine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • thiotepa
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    thiotepa
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + thiotepa

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • tildrakizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    tildrakizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + tildrakizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • tisagenlecleucel
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    tisagenlecleucel
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + tisagenlecleucel

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • tocilizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    tocilizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + tocilizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • tofacitinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    tofacitinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + tofacitinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • topotecan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    topotecan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + topotecan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • trabectedin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    trabectedin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + trabectedin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • tralokinumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    tralokinumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + tralokinumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • triamcinolone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    triamcinolone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + triamcinolone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ublituximab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ublituximab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ublituximab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • upadacitinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    upadacitinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + upadacitinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • ustekinumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    ustekinumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + ustekinumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • vamorolone
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    vamorolone
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + vamorolone

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • vedolizumab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    vedolizumab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + vedolizumab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • venetoclax
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    venetoclax
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + venetoclax

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • vilobelimab
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    vilobelimab
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + vilobelimab

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • vinblastine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    vinblastine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + vinblastine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • vincristine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    vincristine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + vincristine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • vinorelbine
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    vinorelbine
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + vinorelbine

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • voclosporin
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    voclosporin
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + voclosporin

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • zanubrutinib
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    zanubrutinib
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + zanubrutinib

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • zilucoplan
  • Adstiladrin (nadofaragene firadenovec-vncg) (nadofaragene firadenovec intravesical)
    +
    zilucoplan
    1 interaction

    Caution Advised

    nadofaragene firadenovec intravesical + zilucoplan

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@1c2e0e85
  • disseminated adenovirus infection risk (immunocompromised patients)
  • hematuria

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@3cad68b8
  • instillation site discharge
  • fatigue
  • bladder spasm
  • urinary urgency
  • hematuria
  • rigors
  • dysuria
  • fever
  • glucose incr.
  • triglycerides incr.
  • Cr incr.
  • phosphate decr.
  • Hgb decr.

Safety/Monitoring .

Monitoring Parameters
pregnancy test at baseline

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; no human or animal data available

Individuals of Reproductive Potential

obtain pregnancy test before tx start; avoid pregnancy by using effective contraception during tx and x6mo after D/C in patients of childbearing potential and during tx and x3mo after D/C in male patients

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@5862cbab

Metabolism: for nadofaragene firadenovec: other; CYP450: unknown

Excretion: for nadofaragene firadenovec: unknown; Half-life: unknown

Subclass: Gene Therapy, Interferons

Mechanism of Action
for nadofaragene firadenovec: delivers copy of human interferon alfa-2b (IFNa2b) gene via adenoviral vector to bladder urothelium, leading to transient local expression of IFNa2b protein

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Ferring Pharmaceuticals Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@7934d2b6

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information